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Is there a problem with the equivalent air 
altitude concept to assess hypobaric 
hypoxia?
Is there a medical concern about secondary 
polycythemia?
A bed rest hypoxia study can help.  
equivalent air altitude concept
Rahn H, Fenn WO.  A graphical analysis of the respiratory 
gas exchange: the O2 - CO2 diagram. 2nd ed.  Washington, DC:
The American Physiological Society; 1956:38, from a 1935
reference.
21% O2 @ 10,000 ft
or
50% O2 @ 28,000 ft
or
14% O2 @ 0 ft (sea level)
etc.
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 Underlying Assumptions:
 Efficient and frequent EVAs will drive exploration program.
 Low pressure suit is always preferred to high pressure suit. 
 There is operational value to a short in-suit prebreathe. 
 Vehicle atmosphere may not prevent risk of DCS during EVA.
 Shuttle and ISS atmospheres are examples.
 Dedicated hyperbaric treatment capability may not be present.
 Atmosphere Design Considerations:
 No significant risk of fire – bad experience with 100% O2.
 Limit hypoxia – you need O2 with every breath.
 Prevent DCS and VGE.
 Better to prevent than treat DCS, or to constantly embolize the lung.
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PIO2 is inspired O2 partial pressure, computed as (PB mmHg – 47) * FIO2 (as decimal fraction).
PAO2 is computed acute alveolar oxygen partial pressure from alveolar oxygen equation.
*Conkin J, Wessel JH III.  Critique of the equivalent air altitude model.  Aviat Space Environ Med 
2008; 79:975-82.
*Conkin J, Wessel JH III.  A model to predict acute mountain sickness in future spacecraft.  NASA 
Technical Publication NASA/TP-2009-214791, Johnson Space Center, July 2009.    
equivalent air altitude model - ascent on enriched O2
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Signs and symptoms include headache, nausea, 
dizziness, fatigue, vomiting and sleeplessness 
following a recent gain in altitude with at least several 
hours at the new altitude in a hypoxic environment; 
likened to a bad hangover.
acute mountain sickness
 The incidence of AMS is highly variable.
- Roach (1998) reports that 25% of people are affected by a quick ascent 
to 2,000 m (6,600 ft).
- Montgomery (1989) shows 25% incidence of three or more symptoms 
at 2,000 m and that half with these symptoms took medication for 
relief of symptoms.
- Houston (1982) starts his list of AMS symptoms at altitudes above 
2,100 m (7,000 ft).
- Muhm (2007) reports 11% AMS in large sample during 20 hrs at 2,438 
m (8,000 ft).
 So about 15% expected at 7,000 ft.
 How do results from these actual altitudes translate to 
our equivalent air altitudes?
 Rahn and Fenn (1956) disproved the simple notion of 
equivalent air altitude, and conclude, “It is evidently not 
enough to equate the inspired O2 tensions …”
 Since 1980s researchers have questioned the 
conventional wisdom that the symptoms of AMS are 
solely due to low O2 partial pressure.
 Accumulated anecdotal evidence shows descent is more 
effective for relief of AMS than enriched O2 alone.
 Savourey (2003) speaks of the “specific response to 
hypobaric hypoxia”.






























































































































































































































normobaric hypoxia, hypobaric hypoxia, and hypobaric normoxia
 The pressure effect is real, so to understand the 
total hypoxic stress means you have to 
understand the interaction between hypoxic 
PIO2 and PB. 
 Any bed rest hypoxia study should use the 
actual atmospheric conditions and not the 

























































 Are astronauts at potential risk for AMS?  About 
25% worst case probability (guesstimate) with 0% 
once acclimatization occurs.
 This is baseline estimate given direct ascent to 8.0 
psia with 32% O2 and no consideration of µG-AMS 
interaction.
 Greater potential risk of AMS than the current EAAs 
suggest.
- Finalize a plan to mitigate the risk even if risk is 
unclear.
- Take the opportunity to quantify the risk with 
focused research.

large sample Chinese study -- 2003 
filled bars are female
black bar is female
Miao Ge.  Creating an altitude-adjusted hematocrit reference standard for adults 18-40 years of age 
in China.  Arc of Environ Health 2003.
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5%  PV, 16.5 
to 17.5 g/dl HB 
20%  PV, 16.5 
to 19.0 g/dl HB 
 
 
hypoxia plus bed rest  - all there is
*   only 8 hrs were at 8,000 ft (PIO2 was 108 mmHg)
**  normoxic 6-HD
+   hypoxic exposure only 
#   subjects lived at 5,400 ft (PIO2 was 120 mmHg)
 Does μG modify the likelihood or character of 
AMS? 
 Redistribution of lung fluid – 25% increase in CapBV  
 Increased interstitial edema – puffy face response
 Increased incidence of HAPE?
 Potential negative synergy on combining mild 
hypoxia and adaptation to μG – increase in 
hematocrit leads to increased blood viscosity.
 Six reports suggest this may not be a significant 
concern – keep hematocrit below 55%.
 Baseline “worst case” potential risk of AMS is about 
25% based on direct ascent to 8.0 psia with 32% O2.
 EAA model should be replaced with an iso-hypoxic model.
 Staged depressurization scheme is a practical mitigation approach.
 Current depressurization to 10.2 psia in CEV and 4-day transit to 
moon is not anticipated to induce signs or symptoms of AMS. 
 Eventual transition to LSAM at 8.0 psia and 32% O2 after some 
acclimatization will reduce potential risk << 25%, but precise 
estimate is not yet available.
 Due to uncertainty about potential AMS risk:
 Flight Surgeons should prepare. 
 Focused research should proceed.
 Current analytical efforts should continue.
Questions ?
 Based on this 1991 committee’s recommendations:
 A diagnosis of AMS is based on a recent gain in altitude, at 
least several hours (>2) at the new altitude, and the presence of 
headache and at least one of the following symptoms: 
gastrointestinal upset, fatigue or weakness, dizziness or 
lightheadedness and difficulty sleeping. 
 A score of three points or greater on the AMS Self-Report 
Questionnaire alone or in combination with the clinical 
assessment score is diagnostic of AMS.
 Several signs and symptoms of AMS are shared with 
motion sickness – confounding a diagnosis of each!
1. Headache 0 No headache
1 Mild Headache
2 Moderate Headache
3 Severe Headache, incapacitating
2. Gastrointestinal 
Symptoms 0 No gastrointestinal symptoms
1 Poor appetite or nausea
2 Moderate nausea or vomiting
3 Severe nausea & vomiting, incapacitating
3. Fatigue and/or 
Weakness 0 Not tired or weak
1 Mild fatigue/weakness
2 Moderate fatigue/weakness
3 Severe fatigue / weakness, incapacitating
4. Dizziness / 
lightheadedness 0 Not Dizzy
1 Mild dizziness
2 Moderate dizziness
3 Severe dizziness, incapacitating
5. Difficulty sleeping 0 Slept as well as usual
1 Did not sleep as well as usual
2 Woke many times, poor night's sleep
3 Could not sleep at all
Self Report 
Questionnaire
Each question asked and 
the sum is calculated as 
the AMS self report score.
6. Change in Mental 
Status 0 No Change in Mental Status
1 Lethargy /  lassitude
2 Disoriented/confused
3 Stupor / semiconsciousness
4 Coma
7. Ataxia (heel to toe 
walking) 0 No Ataxia
1 Maneuvers to maintain balance
2 Steps off line
3 Falls down
4 Can't stand
8. Peripheral Edema 0 No peripheral edema
1 Peripheral edema at one location
2 Edema at two or more locations
Clinical Assessment
The interviewers ratings of 
three signs is added to the 
self-report score.
